// PERSON
Brendan Smith
ROLE DIRECTOR OF LIFE SCIENCES EQUITY RESEARCHMENTIONS 1LAST SEEN JULY 21, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
mention·Axios AI+·JULY 21, 2026
“The hope is to 'create more shots on goal,' says Brendan Smith, director of life sciences equity research at TD Cowen, and to generate large amounts of data that can train the AI models to increase the odds of clinical success.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.